---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-034692"
form_type: "8-K"
ticker: "NOTV"
cik: "0000720154"
company_name: "Inotiv, Inc."
filed_at: "2023-10-19T23:59:59+00:00"
generated_at: "2026-06-09T21:18:24.600084+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Inotiv appoints Terry Coelho to board, replacing Richard Johnson effective Oct 16, 2023

## Summary
- Richard A. Johnson resigned as director; Terry Coelho appointed as Class II director.
- Coelho also joins Compensation, Audit, and chairs Nominating/Corporate Governance committees.
- Coelho is CFO of Gamida Cell; previously led CinCor Pharma's $190M IPO and its sale to AstraZeneca.
- Director annual cash retainer $55,000; committee chairs/members receive additional retainers.
- Coelho granted 12,911 restricted stock units as initial equity award.

## SEC filing metadata
- accession: 0001628280-23-034692
- form_type: 8-K
- ticker: NOTV
- cik: 0000720154
- company_name: Inotiv, Inc.
- filed_at: 2023-10-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/720154/000162828023034692/0001628280-23-034692-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/720154/000162828023034692/notv-20231016.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-034692
- JSON: https://secwatch.observer/filing/0001628280-23-034692.json
- Plain text: https://secwatch.observer/filing/0001628280-23-034692.txt

## Key facts
- Executive change
  Terry Coelho was appointed as Director at Inotiv, Inc..
  - Action: appointed
  - Role: Director
  source text: The Board has appointed Terry Coelho to the Board, effective October 16, 2023, to serve as a Class II director of the Company for a term ending at the Annual Meeting of Shareholders in 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/720154/000162828023034692/0001628280-23-034692-index.htm
- Executive change
  Richard A. Johnson resigned as Director at Inotiv, Inc..
  - Action: resigned
  - Role: Director
  source text: Richard A. Johnson, Ph.D. previously tendered his resignation as a director of the Company, to be effective automatically upon notice to Dr. Johnson from the Company that the Board of Directors (the "Board") is prepared to elect an approved director as provided in the Shareholders Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/720154/000162828023034692/0001628280-23-034692-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.